NASDAQ:ACHV

Achieve Life Sciences Stock News

Healthcare > Biotechnology

Buy ACHV

*Your capital is at risk

$6.10

-0.0100 (-0.164%)

At Close: Jul 13, 2026

Infosys: Mixed Quarter But Central Buy Thesis Remains Firm

12:30pm, Wednesday, 13'th May 2020

During the quarter, revenue growth was strongly driven by digital business. Life Sciences vertical came in the strongest with 11.9% Y/Y revenue growth. There we

Analysis on Impact of Covid-19- Global Respiratory Syncytial Virus Diagnostics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Becton, Dickinson and Co. | Technavio

12:00am, Wednesday, 13'th May 2020

The respiratory syncytial virus (RSV) diagnostics is poised to grow by USD 585.17 mn during 2020-2024, according to Technavio

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by